Go

Breaking News on Supplements & Nutrition - North America EU edition

All feeds

News headlines > Regulation

FTC issues revised guides on use of endorsements

06-Oct-2009 - Companies will need to disclose if they have sponsored a study discussed in an advertisement for their product under new guidance issued yesterday by the US Federal Trade Commission (FTC).

Weekly comment

Bad day at the EU health claims office

05-Oct-2009 - October 1 was not a good day for many in the functional foods and food supplements business in the European Union as the meaning of life under a highly restrictive health claims regime came more into focus.

CSPI files against Bayer as selenium claim products not recalled

01-Oct-2009 - The Center for Science in the Public Interest says it has filed a lawsuit against Bayer over claims on One A Day supplements that selenium could prevent prostate cancer, on the grounds that existing products bearing the claim were not recalled.

News in brief

FDA develops new ways to spread recall information

30-Sep-2009 - The Food and Drug Administration (FDA) has issued a strategic plan for risk communication that outlines ways in which it will let consumers and health professionals know about the products it regulates.

Senator moots premarket approval for supplements

30-Sep-2009 - Senator Arlen Specter put forward the idea of premarket government approval for dietary supplements at a senate hearing yesterday on hidden steroids in body building products.

Neptune accused of costing krill client $1m

29-Sep-2009 - Neptune Technologies and Bioressources is locked in a dispute with a Utah-based dietary supplement manufacturer that accuses the leading krill extract supplier of reneging on supply commitments and costing it $1m.

Industry prepares for battle at hidden steroid hearing

29-Sep-2009 - Supplement industry stalwarts and critics are preparing to trade blows today at a senate committee hearing on hidden steroids in body building products.

General Mills sued over probiotic claims

28-Sep-2009 - The legal firm that mounted the class action against Dannon that resulted in a $35m out-of-court settlement, is one of several law firms that have mounted a similar action against another probiotic product, this time General Mills’ Yo-Plus.

News in brief

Senate committee to hold meeting on hidden steroids

25-Sep-2009 - A senate committee will next week hold a hearing on hidden steroids in body building products, with participants including food industry representatives, food lawyers and government agencies.

FDA ‘motivates’ firms to correct violations

25-Sep-2009 - A warning letter close-out process implemented this month by the US Food and Drug Administration (FDA) hopes to encourage firms to take corrective action – but so far even responses to warning letters are lacking.

Special edition: Brain health

Regulation: Communicating cognitive health

25-Sep-2009 - In the sixth article in our series on brain health, regulations governing the area are explored.

Dannon probiotic claims: 'Ripped' or 'enhanced'?

24-Sep-2009 - Reaction to Dannon’s $35m out-of-court probiotic settlement has been varied – from those accusing the company of scientific and marketing negligence to staunch defense of the company’s right to market products even when the science is not conclusive.

Analysis: The details of Dannon's probiotic settlement

22-Sep-2009 - Dannon’s out-of-court settlement of the $300m class action mounted against it the beginning of last year contains some interesting clauses such as the fact Dannon has only committed to altering its on-pack immunity marketing for three years.

Dannon pulls 'immunity' claim from probiotic drinks

21-Sep-2009 - Dannon is removing the word “immunity” from its DanActive probiotic drink on-package marketing after concluding an out-of-court settlement last week over alleged misleading probiotic claims.

Weekly comment

Are health claims curbing freedom of speech?

21-Sep-2009 - The US FDA is being sued over its health claims regime – actions that are unlikely to succeed according to most pundits – but they raise serious questions about healthy food messaging and free speech that are being felt globally.

Special edition: Market insights

F&S: Food-drug borderline – approach with caution

17-Sep-2009 - Manufacturers of functional foods and supplements risk losing time, money and brand integrity if they don’t get their marketing story straight. Frost & Sullivan takes a look at the dangers of crossing into the realm of drugs as part of a NutraIngredients series canvassing analyst insight.

News in brief

FDA raps supplements firm over drug claims

16-Sep-2009 - The Food and Drug Administration has told Californian-based supplements manufacturer, EFT Biotech Holdings, claims it has been making about products such as Colostrum #3008, GlucoBalance #3017 and VisionPlus #3012 are drug-like and must be ceased.

Discretionary food fortification is a no go, confirms Canada

15-Sep-2009 - Canadian food regulator Health Canada has said it has no plans to implement proposed legislation for the discretionary fortification of food.

Health Canada to propose heart health claims for food

14-Sep-2009 - The Canadian government is preparing proposals to allow the use of health claims on food labels that would highlight the heart health benefits of certain compounds.

Weekly comment

Bisphenol A: Hearts versus minds

14-Sep-2009 - Forget GMO and nanotechnology - the biggest food safety issue of our times is bisphenol A (BPA).

Special edition: resveratrol

Regulation: Resveratrol from GRAS to novel foods

11-Sep-2009 - As with many relatively new ingredients, resveratrol has had to prove its safety and efficacy to gain regulatory approval in various markets since its widespread commercial availability in the early 1990s.

More fines for bogus immunity claims

10-Sep-2009 - The Federal Trade Commission has charged another national retailer with making misleading and unsubstantiated claims about a dietary supplement.

Supplement defender Harkin takes US health chair

10-Sep-2009 - Long-time friend of the supplements industry Senator Tom Harkin will replace the late Edward Kennedy as head of the US Senate health committee.

Martek scores patent victory over omega-3 rival

09-Sep-2009 - Martek Biosciences Corporation has scored a significant victory in its long-running omega-3 patent infringement case against Swiss supplier Lonza.

News in brief

US rule sets pomegranate pesticide levels

03-Sep-2009 - A new regulation published yesterday has established tolerances for residues of methoxyfenozide in pomegranate, following a petition from agricultural giant DowAgrosciences.

Sign up for your free newsletter